Wordt geladen...
Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives
Rhenium-188 ((188)Re) is a high energy beta-emitting radioisotope with a short 16.9 h physical half-life, which has been shown to be a very attractive candidate for use in therapeutic nuclear medicine. The high beta emission has an average energy of 784 keV and a maximum energy of 2.12 MeV, sufficie...
Bewaard in:
| Gepubliceerd in: | Front Med (Lausanne) |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587137/ https://ncbi.nlm.nih.gov/pubmed/31259173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00132 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|